Rastall Andrew C, Getting Dominic, Goddard Jon, Roberts David R, Erdinger Lothar
Institute of Hygiene and Medical Microbiology, University of Heidelberg, Germany.
Environ Sci Pollut Res Int. 2006 Jul;13(4):256-67. doi: 10.1065/espr2005.12.290.
GOAL, SCOPE AND BACKGROUND: Some anthropogenic pollutants posses the capacity to disrupt endogenous control of developmental and reproductive processes in aquatic biota by activating estrogen receptors. Many anthropogenic estrogen receptor agonists (ERAs) are hydrophobic and will therefore readily partition into the abiotic organic carbon phases present in natural waters. This partitioning process effectively reduces the proportion of ERAs readily available for bioconcentration by aquatic biota. Results from some studies have suggested that for many aquatic species, bioconcentration of the freely-dissolved fraction may be the principal route of uptake for hydrophobic pollutants with logarithm n-octanol/water partition coefficient (log Kow) values less than approximately 6.0, which includes the majority of known anthropogenic ERAs. The detection and identification of freely-dissolved readily bioconcentratable ERAs is therefore an important aspect of exposure and risk assessment. However, most studies use conventional techniques to sample total ERA concentrations and in doing so frequently fail to account for bioconcentration of the freely-dissolved fraction. The aim of the current study was to couple the biomimetic sampling properties of semipermeable membrane devices (SPMDs) to a bioassay-directed chemical analysis (BDCA) scheme for the detection and identification of readily bioconcentratable ERAs in surface waters.
SPMDs were constructed and deployed at a number of sites in Germany and the UK. Following the dialytic recovery of target compounds and size exclusion chromatographic cleanup, SPMD samples were fractionated using a reverse-phase HPLC method calibrated to provide an estimation of target analyte log Kow. A portion of each HPLC fraction was then subjected to the yeast estrogen screen (YES) to determine estrogenic potential. Results were plotted in the form of 'estrograms' which displayed profiles of estrogenic potential as a function of HPLC retention time (i.e. hydrophobicity) for each of the samples. Where significant activity was elicited in the YES, the remaining portion of the respective active fraction was subjected to GC-MS analysis in an attempt to identify the ERAs present.
Estrograms from each of the field samples showed that readily bioconcentratable ERAs were present at each of the sampling sites. Estimated log Kow values for the various active fractions ranged from 1.92 to 8.63. For some samples, estrogenic potential was associated with a relatively narrow range of log Kow values whilst in others estrogenic potential was more widely distributed across the respective estrograms. ERAs identified in active fractions included some benzophenones, various nonylphenol isomers, benzyl butyl phthalate, dehydroabietic acid, sitosterol, 3-(4-methylbenzylidine)camphor (4-MBC) and 6-acetyl-1,1,2,4,4,7-hexamethyltetralin (AHTN). Other tentatively identified compounds which may have contributed to the observed YES activity included various polycyclic aromatic hydrocarbons (PAHs) and their alkylated derivatives, methylated benzylphenols, various alkyl-phenols and dialkylphenols. However, potential ERAs present in some active fractions remain unidentified.
Our results show that SPMD-YES-based BDCA can be used to detect and identify readily bioconcentratable ERAs in surface waters. As such, this biomimetic approach can be employed as an alternative to conventional methodologies to provide investigators with a more environmentally relevant insight into the distribution and identity of ERAs in surface waters. The use of alternative bioassays also has the potential to expand SPMD-based BDCA to include a wide range of toxicological endpoints. Improvements to the analytical methodology used to identify ERAs or other target compounds in active fractions in the current study could greatly enhance the applicability of the methodology to risk assessment and monitoring programmes.
目标、范围及背景:一些人为污染物能够通过激活雌激素受体来干扰水生生物发育和生殖过程的内源性调控。许多人为雌激素受体激动剂(ERA)具有疏水性,因此会很容易分配到天然水体中的非生物有机碳相中。这种分配过程有效地降低了水生生物易于生物富集的ERA比例。一些研究结果表明,对于许多水生物种而言,自由溶解部分的生物富集可能是对数正辛醇/水分配系数(log Kow)值小于约6.0的疏水性污染物的主要吸收途径,这其中包括了大多数已知的人为ERA。因此,检测和识别自由溶解且易于生物富集的ERA是暴露和风险评估的一个重要方面。然而,大多数研究使用传统技术来采样总ERA浓度,这样做常常无法考虑自由溶解部分的生物富集情况。本研究的目的是将半透膜装置(SPMD)的仿生采样特性与生物测定导向化学分析(BDCA)方案相结合,用于检测和识别地表水中易于生物富集的ERA。
构建SPMD并部署于德国和英国的多个地点。在对目标化合物进行透析回收并通过尺寸排阻色谱法净化后,使用经校准以估算目标分析物log Kow的反相HPLC方法对SPMD样品进行分离。然后将每个HPLC馏分的一部分进行酵母雌激素筛选(YES)以确定雌激素潜力。结果以“雌激素图”的形式绘制,该图显示了每个样品的雌激素潜力随HPLC保留时间(即疏水性)变化的曲线。如果在YES中引发了显著活性,则对相应活性馏分的其余部分进行GC-MS分析,以尝试鉴定其中存在的ERA。
每个现场样品的雌激素图表明,每个采样地点都存在易于生物富集的ERA。各种活性馏分的估计log Kow值范围为1.92至8.63。对于一些样品,雌激素潜力与相对较窄的log Kow值范围相关,而在其他样品中,雌激素潜力在各自的雌激素图中分布更广泛。在活性馏分中鉴定出的ERA包括一些二苯甲酮、各种壬基酚异构体邻苯二甲酸苄基丁酯、脱氢枞酸、甾醇、3-(4-甲基亚苄基)樟脑(4-MBC)和6-乙酰基-1,1,2,4,4,7-六甲基四氢化萘(AHTN)。其他可能导致观察到的YES活性的初步鉴定化合物包括各种多环芳烃(PAH)及其烷基化衍生物、甲基化苄基酚、各种烷基酚和二烷基酚。然而,一些活性馏分中存在的潜在ERA仍未鉴定出来。
我们的结果表明,基于SPMD-YES的BDCA可用于检测和识别地表水中易于生物富集的ERA。因此,这种仿生方法可作为传统方法的替代方法,为研究人员提供关于地表水中ERA的分布和特性的更符合环境实际情况的见解。使用替代生物测定法也有可能将基于SPMD的BDCA扩展到包括广泛的毒理学终点。改进本研究中用于鉴定活性馏分中的ERA或其他目标化合物的分析方法,可大大提高该方法在风险评估和监测计划中的适用性。